Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
QGEN
$48.04
Qiagen N.V.
($.32)
(.66%)
QGEN
Earnings Whisper ®
N/A
3rd Quarter September 2025
Consensus: $0.59
Revenue: $522.77 Mil
Tuesday
Nov 4
4:05 PM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Guidance announcement made Tuesday, August 5, 2025
Latest EPS
Tuesday, August 5, 2025
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
What do you expect when QGEN reports earnings?
Beat
Meet
Miss
Where is QGEN's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$48.76
$48.45
$48.25
$47.94
Support
$47.73
$47.42
$47.22
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Peers
Biogen
Amgen
Gilead Sciences
Neurocrine Biosciences
Repligen
Bio-Techne
BioCryst Pharmaceuticals
Stem
Novavax
Sangamo Therapeutics
Expectations
›
Qiagen N.V.